Keywords: schizophrenia, symptoms, cut, lurasidone, japan-based, dainippon, sumitomo

Schizophrenia symptoms cut by lurasidone

Article | 26 May 2009

Japan-based Dainippon Sumitomo Pharma presented positive results from the first Phase III trial of lurasidone, which is under clinical development ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Dainippon Sumitomo Pharma

Go to company listing